Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus

Amy L Pasternak,1 Vincent D Marshall,1 Christina L Gersch,2 James M Rae,2 Michael Englesbe,3 Jeong M Park1 1Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, 48109, USA; 2Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, 48109, USA; 3Departm...

Full description

Bibliographic Details
Main Authors: Pasternak AL, Marshall VD, Gersch CL, Rae JM, Englesbe M, Park JM
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
pharmacogenetics
cost of care
pediatric transplant
Online Access:https://www.dovepress.com/evaluating-the-impact-of-cyp3a5-genotype-on-post-transplant-healthcare-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/evaluating-the-impact-of-cyp3a5-genotype-on-post-transplant-healthcare-peer-reviewed-article-PGPM

Similar Items